Correction to: Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.

Journal

Journal of experimental & clinical cancer research : CR
ISSN: 1756-9966
Titre abrégé: J Exp Clin Cancer Res
Pays: England
ID NLM: 8308647

Informations de publication

Date de publication:
06 07 2020
Historique:
entrez: 7 7 2020
pubmed: 7 7 2020
medline: 7 7 2020
Statut: epublish

Résumé

An amendment to this paper has been published and can be accessed via the original article.

Identifiants

DOI: 10.1186/s13046-020-01635-6 PMID: 32624003 PMC: PMC7336403
pubmed: 32624003
doi: 10.1186/s13046-020-01635-6
pii: 10.1186/s13046-020-01635-6
pmc: PMC7336403
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

125

Commentaires et corrections

Type : ErratumFor

Références

J Exp Clin Cancer Res. 2020 May 5;39(1):76
pubmed: 32370786

Auteurs

Zhiyan Hu (Z)

Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Ting Long (T)

Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Yidan Ma (Y)

Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Jiaxian Zhu (J)

Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Lingfang Gao (L)

Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Yan Zhong (Y)

Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Xia Wang (X)

Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Xiaoyan Wang (X)

Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China.

Zuguo Li (Z)

Department of Pathology, Shenzhen Hospital of Southern Medical University, Shenzhen, China. Lizg@smu.edu.cn.
Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. Lizg@smu.edu.cn.
Guangdong Provincial Key Laboratory of Molecular tumor Pathology, Guangzhou, China. Lizg@smu.edu.cn.

Classifications MeSH